Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat Zsuzsanna BohárGábor Nagy-GróczÁrpád Párdutz Translational Neurosciences - Original Article 23 August 2015 Pages: 1621 - 1631
Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson’s disease Chi Wang IpSandra K. BeckJens Volkmann Translational Neurosciences - Original Article 20 August 2015 Pages: 1633 - 1643
G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system Qian XiaoSuosuo YangWeidong Le Neurology and Preclinical Neurological Studies - Original Article 08 August 2015 Pages: 1645 - 1657
Small intestine dysfunction in Parkinson’s disease Justyna DutkiewiczStanisław SzlufikAndrzej Friedman Neurology and Preclinical Neurological Studies - Short communication Open access 26 August 2015 Pages: 1659 - 1661
Characteristic laryngoscopic findings in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder Takashi TsuboiHirohisa WatanabeGen Sobue Neurology and Preclinical Neurological Studies - Original Article 09 August 2015 Pages: 1663 - 1672
Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS) Alexander StorchChristine B. SchneiderGeorg Ebersbach Neurology and Preclinical Neurological Studies - Original Article 12 August 2015 Pages: 1673 - 1684
Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson’s disease Jung Han YoonDong Kyu ParkJi Man Hong Neurology and Preclinical Neurological Studies - Original Article 05 September 2015 Pages: 1685 - 1691
Generalized motor inhibitory deficit in Parkinson’s disease patients who freeze Patrick G. BissettGordon D. LoganScott A. Wylie Neurology and Preclinical Neurological Studies - Original Article 09 September 2015 Pages: 1693 - 1701
Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study Maria Elena Di BattistaAlfonso RubinoGiuseppe Meco Neurology and Preclinical Neurological Studies - Short communication 28 August 2015 Pages: 1703 - 1706
Erratum to: Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study Maria Elena Di BattistaAlfonso RubinoGiuseppe Meco Erratum 06 November 2015 Pages: 1707 - 1707
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off Mikko KuoppamäkiMika LeinonenWerner Poewe Neurology and Preclinical Neurological Studies - Original Article Open access 07 September 2015 Pages: 1709 - 1714
Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer’s disease Sigrun RoeberFelix Müller-SarnowskiHans A. Kretzschmar Neurology and Preclinical Neurological Studies - Short communication 08 September 2015 Pages: 1715 - 1719
Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence Siok Ching ChiaJeyakumar HenryKang Sim Psychiatry and Preclinical Psychiatric Studies - Review Article 09 September 2015 Pages: 1721 - 1732